Concepedia

Mohammed Wattad

MW

Statistics

Publications

28

Citations

4.3K

H-Index

23

Active since

2010

Affiliations

Medizinische Hochschule Hannover(Current)

University Hospital Ulm

Universität Hamburg

Heinrich Heine University Düsseldorf

University Hospital Bonn

Mohammed Wattad is an author at Medizinische Hochschule Hannover specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

2010–2023

28

Publications

28

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

, , +17

Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen et al. · Journal of Clinical Oncology · 2011 · 394 citations · Full text

, , +15

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi et al. · Journal of Clinical Oncology · 2016 · 392 citations · Full text

, , +12

Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)

Peter Paschka, Juan Du, Richard F. Schlenk et al. · Blood · 2012 · 183 citations

, , +14

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka et al. · Blood · 2013 · 178 citations

, , +15

1–5 of 28